Related Experiment Video
Updated: Mar 19, 2026
03:08
Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
1.1K
Efficient Drug-Pathway Association Analysis via Integrative Penalized Matrix Decomposition
Summary
We developed iPaD, a new computational method for pathway-based drug discovery. iPaD efficiently identifies drug-pathway associations from large datasets, outperforming existing methods.
Area of Science:
- Computational biology
- Pharmacogenomics
- Systems biology
Background:
- Traditional drug discovery focuses on single targets, neglecting disease complexity.
- Pathway-based drug discovery offers a more holistic approach by considering biological pathways.
- High-throughput data enables the identification of drug-pathway associations.
Purpose of the Study:
- To develop an integrative method, iPaD, for identifying associations between drugs and biological pathways.
- To leverage high-throughput transcription and drug sensitivity data for improved drug discovery.
- To enhance computational efficiency in analyzing large-scale biological datasets.
Main Methods:
- Developed iPaD, an integrative Penalized Matrix Decomposition method.
- Jointly modeled high-throughput transcription and drug sensitivity data.
- Implemented a scalable bi-convex optimization algorithm for computational efficiency.
Main Results:
- iPaD demonstrated superior computational efficiency compared to state-of-the-art methods.
- The method successfully handled large-scale datasets.
- iPaD identified a significantly higher number of validated drug-pathway associations on real datasets.
Conclusions:
- iPaD provides an efficient and effective approach for pathway-based drug discovery.
- The method advances the identification of drug-pathway associations for complex diseases.
- Publicly available code facilitates broader adoption and further research.
Related Concept Videos
01:09Pharmacodynamic Models: Additive and Proportional Drug Effect Model
55
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
55
00:59Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
389
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
389
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
67
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
67
01:21Mechanistic Models: Overview of Compartment Models
465
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
465
01:29Pharmacogenomics: Identification of New Drug Targets
75
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
75
01:14Model Approaches for Pharmacokinetic Data: Compartment Models
713
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
713